Clinical Trials

Clinical trials are research studies that test whether new medical treatments, devices or strategies  are safe and effective.

People who volunteer for clinical trials play an active role in their own health care, often gain access to experimental treatments, and help others by improving and advancing medical care.

At Providence Cancer Center, our scientists and physicians work closely together to make clinical trials a regular part of cancer care. Patients may take part in studies initiated by our translational researchers at the Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute, in addition to studies sponsored by the National Cancer Institute or pharmaceutical and biotechnology companies.

Our clinical trials team works directly with physicians to identify clinical trials appropriate for their patients’ specific stage of disease.

The goals of clinical research vary from trial to trial. Generally, they are designed to:

  • Improve prevention, early diagnosis and treatment of cancer
  • Discover whether a particular drug  or medical treatment is safe and effective
  • Advance the state of scientific and medical knowledge
  • Measure and improve the quality of life for patients and their families
Find cancer clinical trials available in Oregon in the list below. You may search by keyword or condition/disease, or browse using the page numbers and arrows. Find additional trials by using the search term “Oncology Multiple Tumor Sites". To learn more about a particular trial and qualification criteria, click the trial name and then the listed contact link, or talk with your physician.

For more information about clinical trials available through Providence Cancer Center, call 503-215-6014
« Previous 12345 Next »
Viewing Page 1 of 23 | Showing Results 1 - 5 of 114

A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment Of HER2-Overexpressing Esophageal Adenocarcinoma

This randomized phase III trial studies how well radiation therapy, paclitaxel, and carboplatin with or without trastuzumab work in treating...

Matthew Solhjem MD
  • Clackamas Radiation Oncology Center
  • Compass Oncology East
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus CELECOXIB or Placebo for Patients with Resected Stage III Colon Cancer

This randomized phase III trial is studying giving oxaliplatin, leucovorin calcium, and fluorouracil together to compare how well they work when...

Alison Conlin MD
  • Clackamas Radiation Oncology Center
  • Oncology and Hematology Care Eastside
  • Oncology and Hematology Care Southeast
  • Oncology and Hematology Care Westside
  • Providence Newberg Medical Center
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
  • Providence Willamette Falls Medical Center

A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision

This randomized phase II/III trial studies how well chemotherapy alone compared to chemotherapy plus radiation therapy works in treating patients...

Alison Conlin MD
  • Clackamas Radiation Oncology Center
  • Oncology and Hematology Care Southeast
  • Providence Newberg Medical Center
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

A Phase III Trial Evaluating both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

This randomized phase II-R/III trial studies gemcitabine hydrochloride with or without erlotinib hydrochloride followed by the same chemotherapy...

Matthew Solhjem MD
  • Clackamas Radiation Oncology Center
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

A Phase 3 Open-Label, Randomized, Multicenter Study of Imprime PGG® in Combination with Cetuximab (Erbitux®) in Subjects with Recurrent or Progressive KRAS Wild Type Colorectal Cancer (Protocol BT-CL-PGG-CRC1031)

This study is a Phase 3, open-label, randomized, multi-center study. Qualified subjects, who have KRAS wild type (WT) colorectal cancer will be...

Todd Crocenzi MD
  • Providence Medford Medical Center
  • Providence Milwaukie Hospital
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
« Previous 12345 Next »
Viewing Page 1 of 23 | Showing Results 1 - 5 of 114